Pain
Commentary
How precision psychiatry helped my patient; Ketamine: The next ‘opioid crisis’?
I applaud Dr. Nasrallah’s editorial “The dawn of precision psychiatry.” Since the late 1990s, I have been practicing psychiatry in this mode in...
Latest News
FDA advisors recommend lofexidine for opioid withdrawal
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
Feature
Is kratom the answer to the opioid crisis?
Addiction experts say evidence remains sparse about the safety of the botanical product from Southeast Asia.
Daily News Podcast
MDedge Daily News: Why the barber’s chair can help hypertension
And how excessive daytime sleepiness could lead to dementia.
Conference Coverage
The case for being open-minded about medical marijuana
LAS VEGAS – As part of an open approach, educate patients about effective alternative treatments to medical cannabis, an expert advises.
Feature
Opioid prescriptions got shorter in 2017
Pharmacy benefits manager reports increased use of drugs to treat opioid dependence.
From the Journals
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
Chronic pain patients may be able to improve function without increasing risk of addiction.
FDA/CDC
Opioid deaths in the ED increase nationally
Opioid overdose deaths have reached an all-time high across the country.
From the Journals
Serotonin syndrome risk with triptans and antidepressants ‘very low’
Results cast doubt on the validity of the FDA’s advisory warning in 2006.
Opinion
Serotonin syndrome warnings magnify its rare probability
Dr. Allan M. Block wonders why more serious side effects of other drugs aren’t addressed by warnings.
From the Journals
Persistent opioid use a risk after surgery in teens and young adults
Higher initial opioid requirements didn’t necessarily mean persistent opioid use later.